Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance
- 8 December 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 18 (1) , 198-213
Abstract
The aim of this study was to evaluate the benefits of a ternary amorphous solid dispersion (ASD) that was designed as an immediate-release tablet with a high drug load (e.g., 40% w/w) to produce heightened maintenance of drug supersaturation during dissolution testing, which will be henceforth referred to as the “maintenance ability”. Ternary ASD granules were produced by hot melt extrusion (HME) and were comprised of itraconazole (ITZ) 50%, hypromellose (HPMC) 20%, and mesoporous silica (XDP) 30%, where amorphous ITZ incorporated into HPMC was efficiently absorbed in XDP pores. The ternary ASD granules containing a high-viscosity HPMC (AF4M) produced a significantly heightened maintenance ability of drug supersaturation in neutral pH dissolution media in which crystalline ITZ solubility is below 1 μg/mL. The final tablet formulation contained 80% w/w of the ASD granules (40% w/w ITZ), had an acceptable size, and exhibited both sufficient tablet hardness and disintegration. The dissolution behavior of the ternary ASD tablet exhibited a supersaturation maintenance ability similar to that of the ASD granules. Under neutral conditions, the ternary ASD tablet showed immediate and higher ITZ release compared with the binary ASD tablets, and this phenomenon could be explained by the difference in ITZ/AF4M particle size in the tablet. In high-resolution scanning electron microscopy (SEM), it was observed that ITZ and AF4M in the ternary formulation could easily form nano-sized particles (<1 μm) during the absorption process into/onto XDP pores prepared by HME, which contributed to the immediate ITZ release from the ternary ASD tablet under neutral pH conditions. Therefore, the ternary ASD containing high-viscosity HPMC and mesoporous silica prepared by HME made it possible to design a high ASD content, small-size tablet with an ideal dissolution profile in biorelevant media, and we expect that this technology can be applied for continuous HME ASD manufacturing.Keywords
This publication has 63 references indexed in Scilit:
- Mechanisms of increased bioavailability through amorphous solid dispersions: a reviewDrug Delivery, 2019
- Opportunities for Successful Stabilization of Poor Glass-Forming Drugs: A Stability-Based Comparison of Mesoporous Silica Versus Hot Melt Extrusion TechnologiesPharmaceutics, 2019
- Delivery of Poorly Soluble Drugs via Mesoporous Silica: Impact of Drug Overloading on Release and Thermal ProfilesPharmaceutics, 2019
- Glabridin smartPearls – Silica selection, production, amorphous stability and enhanced solubilityInternational Journal of Pharmaceutics, 2019
- Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – An updateInternational Journal of Pharmaceutics, 2018
- Strategies for formulating and delivering poorly water-soluble drugsJournal of Drug Delivery Science and Technology, 2015
- Application of spherical silicate to prepare solid dispersion dosage forms with aqueous polymersInternational Journal of Pharmaceutics, 2015
- Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?Journal of Pharmaceutical Sciences, 2009
- A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and JapanMolecular Pharmaceutics, 2006
- Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying methodInternational Journal of Pharmaceutics, 2005